XML 14 R3.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating expenses:        
Research and development $ 16,783 $ 16,220 $ 53,351 $ 45,493
Selling, general and administrative 16,155 19,908 58,247 60,175
Restructuring 1,600   3,728  
Total operating expenses 34,538 36,128 115,326 105,668
Loss from operations (5,243) (7,447) (31,029) (24,130)
Non-operating expense, net:        
Foreign exchange gain (loss) 166 234 22 (68)
Interest expense (2,364) (1,406) (6,157) (4,134)
Other income (expense), net 233 165 1,159 (647)
Total non-operating expense, net (1,965) (1,007) (4,976) (4,849)
Loss before income taxes (7,208) (8,454) (36,005) (28,979)
Provision for income taxes 78 67 253 221
Net loss (7,286) (8,521) (36,258) (29,200)
Net loss attributable to noncontrolling interest (19) (39) (97) (45)
Net loss attributable to Cerus Corporation $ (7,267) $ (8,482) $ (36,161) $ (29,155)
Net loss per share attributable to Cerus Corporation        
Basic $ (0.04) $ (0.05) $ (0.2) $ (0.17)
Diluted $ (0.04) $ (0.05) $ (0.2) $ (0.17)
Weighted average shares outstanding:        
Basic 180,938 177,236 179,950 176,231
Diluted 180,938 177,236 179,950 176,231
Product        
Revenue $ 39,772 $ 39,571 $ 109,599 $ 118,014
Cost of revenue 17,956 17,662 49,158 55,456
Gross profit 21,816 21,909 60,441 62,558
Government Contract        
Revenue $ 7,479 $ 6,772 $ 23,856 $ 18,980